These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30514835)

  • 1. 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening.
    Hale LJ; Howden SE; Phipson B; Lonsdale A; Er PX; Ghobrial I; Hosawi S; Wilson S; Lawlor KT; Khan S; Oshlack A; Quinlan C; Lennon R; Little MH
    Nat Commun; 2018 Dec; 9(1):5167. PubMed ID: 30514835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Developmental Trajectories of Human Podocyte Inform In Vitro Differentiation of Pluripotent Stem Cell-Derived Podocytes.
    Tran T; Lindström NO; Ransick A; De Sena Brandine G; Guo Q; Kim AD; Der B; Peti-Peterdi J; Smith AD; Thornton M; Grubbs B; McMahon JA; McMahon AP
    Dev Cell; 2019 Jul; 50(1):102-116.e6. PubMed ID: 31265809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes.
    Tanigawa S; Islam M; Sharmin S; Naganuma H; Yoshimura Y; Haque F; Era T; Nakazato H; Nakanishi K; Sakuma T; Yamamoto T; Kurihara H; Taguchi A; Nishinakamura R
    Stem Cell Reports; 2018 Sep; 11(3):727-740. PubMed ID: 30174315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating Human Glomeruli from Pluripotent Stem Cells for Disease Modelling and Drug Screening.
    Hale LJ; Little MH
    Methods Mol Biol; 2023; 2664():55-68. PubMed ID: 37423982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling.
    Jansen J; van den Berge BT; van den Broek M; Maas RJ; Daviran D; Willemsen B; Roverts R; van der Kruit M; Kuppe C; Reimer KC; Di Giovanni G; Mooren F; Nlandu Q; Mudde H; Wetzels R; den Braanker D; Parr N; Nagai JS; Drenic V; Costa IG; Steenbergen E; Nijenhuis T; Dijkman H; Endlich N; van de Kar NCAJ; Schneider RK; Wetzels JFM; Akiva A; van der Vlag J; Kramann R; Schreuder MF; Smeets B
    Development; 2022 May; 149(9):. PubMed ID: 35417019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells.
    Ohmori T; De S; Tanigawa S; Miike K; Islam M; Soga M; Era T; Shiona S; Nakanishi K; Nakazato H; Nishinakamura R
    Sci Rep; 2021 Feb; 11(1):3982. PubMed ID: 33597637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation.
    Sharmin S; Taguchi A; Kaku Y; Yoshimura Y; Ohmori T; Sakuma T; Mukoyama M; Yamamoto T; Kurihara H; Nishinakamura R
    J Am Soc Nephrol; 2016 Jun; 27(6):1778-91. PubMed ID: 26586691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible podocyte injury and proteinuria in transgenic zebrafish.
    Zhou W; Hildebrandt F
    J Am Soc Nephrol; 2012 Jun; 23(6):1039-47. PubMed ID: 22440901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organization of the pronephric filtration apparatus in zebrafish requires Nephrin, Podocin and the FERM domain protein Mosaic eyes.
    Kramer-Zucker AG; Wiessner S; Jensen AM; Drummond IA
    Dev Biol; 2005 Sep; 285(2):316-29. PubMed ID: 16102746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.
    Ito Y; Katayama K; Nishibori Y; Akimoto Y; Kudo A; Kurayama R; Hada I; Takahashi S; Kimura T; Fukutomi T; Katada T; Suehiro J; Beltcheva O; Tryggvason K; Yan K
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1184-F1199. PubMed ID: 28228401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foothold of NPHS2 mutations in primary nephrotic syndrome.
    Jaffer AT; Ahmed WU; Raju DS; Jahan P
    J Postgrad Med; 2011; 57(4):314-20. PubMed ID: 22120861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
    J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
    Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
    Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic kidney diseases disclose the pathogenesis of proteinuria.
    Jalanko H; Patrakka J; Tryggvason K; Holmberg C
    Ann Med; 2001 Nov; 33(8):526-33. PubMed ID: 11730159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GlomSpheres as a 3D co-culture spheroid model of the kidney glomerulus for rapid drug-screening.
    Tuffin J; Chesor M; Kuzmuk V; Johnson T; Satchell SC; Welsh GI; Saleem MA
    Commun Biol; 2021 Dec; 4(1):1351. PubMed ID: 34857869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
    Petrakis I; Mavroeidi V; Stylianou K; Andronikidi E; Lioudaki E; Perakis K; Stratigis S; Vardaki E; Zafeiri M; Giannakakis K; Plaitakis A; Amoiridis G; Saraiva MJ; Daphnis E
    Amyloid; 2013 Sep; 20(3):164-72. PubMed ID: 23829269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1).
    Kuusniemi AM; Merenmies J; Lahdenkari AT; Holmberg C; Salmela K; Karikoski R; Rapola J; Jalanko H
    Kidney Int; 2006 Oct; 70(8):1423-31. PubMed ID: 16941028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome.
    Moschidou D; Corcelli M; Hau KL; Ekwalla VJ; Behmoaras JV; De Coppi P; David AL; Bou-Gharios G; Cook HT; Pusey CD; Fisk NM; Guillot PV
    Stem Cells Dev; 2016 Mar; 25(5):395-404. PubMed ID: 26728561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.
    Boreström C; Jonebring A; Guo J; Palmgren H; Cederblad L; Forslöw A; Svensson A; Söderberg M; Reznichenko A; Nyström J; Patrakka J; Hicks R; Maresca M; Valastro B; Collén A
    Kidney Int; 2018 Dec; 94(6):1099-1110. PubMed ID: 30072040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.